Back to NEO overview

NEO Neogenomics PE ratio, current and historical analysis

The current price-to-earnings ratio of NEO can't be determined, as the TTM EPS of -$0.66 is negative. Neogenomics's last PE ratio on record was 114.86 in September 2021.

NEO PE ratio history

How has NEO's PE ratio performed in the past

The mean historical PE ratio of Neogenomics over the last ten years is 653.49. In the past ten years, NEO's PE ratio reached its highest point in the Jun 2019 quarter at 2,194, with a price of $21.94 and an EPS of $0.01. The Jun 2021 quarter saw the lowest point at 74.05, with a price of $45.17 and an EPS of $0.61.


Neogenomics PE ratio by year

Maximum annual increase: 268.13% in 2020

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 N/A N/A
2020 1,346 268.13%
2019 365.63 102.97%
2018 180.14 N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 208.5 130.39%

NEO average PE ratio chart

What is the average PE ratio of NEO for the past years
3-year avg
5-year avg
10-year avg
15-year avg

NEO PE vs peers

What is NEO's PE ratio compared to its peers
Stock name PE ratio Market cap
ENZ Enzo Biochem Inc 1.23 $58.4M
DGX Quest Diagnostics Inc 19.44 $16.26B
LH Laboratory Corp Of America Holdings 41.86 $18B
RDNT RadNet Inc 188.92 $4.61B
NEO Neogenomics Inc N/A $1.97B

Frequently asked questions

What is Neogenomics's PE ratio?

The current price to earnings ratio of NEO can't be calculated, as its EPS of -$0.66 is negative.

What is the 5-year average PE ratio for Neogenomics (NEO)?

The 5-year average PE ratio for NEO stock is 788.81.

What is the highest PE ratio for NEO?

In the last ten years, the Jun 2019 quarter recorded the highest quarterly PE ratio at 2,194.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.